Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-naïve hepatitis C genotype-1 patients with hepatitis C virus-RNA < 6 million: Single center, real world effectiveness and safety (Q40098679)
Jump to navigation
Jump to search
scientific article published on July 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-naïve hepatitis C genotype-1 patients with hepatitis C virus-RNA < 6 million: Single center, real world effectiveness and safety |
scientific article published on July 2017 |
Statements
1 reference
Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-naïve hepatitis C genotype-1 patients with hepatitis C virus-RNA < 6 million: Single center, real world effectiveness and safety (English)
1 reference
1 reference
Beshoy T Yanny
1 reference
Derenik Gharibian
1 reference
Rita Gevorkyan
1 reference
Amandeep K Sahota
1 reference
1 reference
Identifiers
1 reference